Baidu
map

神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2018 意大利共识：多发性硬化患者认知评估

2018-05-23 国外神经内科相关专家小组（统称） Neurol Sci. 2018 May 15.

多发性硬化认知评估

本文的主要目的是定义多发性硬化患者认知评估的状态，进而为多发性硬化的管理提供指导建议，文章主要内容涉及多发性硬化患者的认知功能以及认知障碍，多发性硬化患者的认知评估和最终建议。

中文标题：

2018 意大利共识：多发性硬化患者认知评估

英文标题：

Cognitive assessment in multiple sclerosis-an Italian consensus.

发布机构：

国外神经内科相关专家小组（统称）

发布日期：

2018-05-23

简要介绍：

本文的主要目的是定义多发性硬化患者认知评估的状态，进而为多发性硬化的管理提供指导建议，文章主要内容涉及多发性硬化患者的认知功能以及认知障碍，多发性硬化患者的认知评估和最终建议。 

拓展指南：与多发性硬化相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 意大利共识：多发性硬化患者认知评估)] GetToolGuiderByIdResponse(projectId=1, id=e56061c001595206, title=2018 意大利共识：多发性硬化患者认知评估, enTitle=Cognitive assessment in multiple sclerosis-an Italian consensus., guiderFrom=Neurol Sci. 2018 May 15., authorId=null, author=, summary=本文的主要目的是定义多发性硬化患者认知评估的状态，进而为多发性硬化的管理提供指导建议，文章主要内容涉及多发性硬化患者的认知功能以及认知障碍，多发性硬化患者的认知评估和最终建议。 , cover=, journalId=null, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Wed May 23 23:05:07 CST 2018, originalUrl=, linkOutUrl=, content=<div>本文的主要目的是定义多发性硬化患者认知评估的状态，进而为多发性硬化的管理提供指导建议，文章主要内容涉及多发性硬化患者的认知功能以及认知障碍，多发性硬化患者的认知评估和最终建议。 </div> <div><br> </div>拓展指南：<strong>与<font color="red">多发性硬化</font>相关指南：</strong><br><ul><li><a title="2018 AAN实践指南建议：成人多发性硬化患者的疾病修饰治疗" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=422aa1c0015838b8">2018 AAN实践指南建议：成人多发性硬化患者的疾病修饰治疗</a></li> <li><a title="2018 实践建议：接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=064b11c00156e7f0">2018 实践建议：接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理</a></li> <li><a title="2018 ECTRIMS/EAN指南：多发性硬化患者的药物治疗" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=0b98c1c0015a6e08">2018 ECTRIMS/EAN指南：多发性硬化患者的药物治疗</a></li> <li><a title="多发性硬化的诊断：2017版McDonald标准" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=3b1b51c0015a20c5">多发性硬化的诊断：2017版McDonald标准</a></li> <li><a title="多发性硬化影像诊断标准：中国专家共识" target="_blank" href="//m.capotfarm.com/guideline/show_article.do?id=2f90c1c001ae7130">多发性硬化影像诊断标准：中国专家共识</a></li> 更多信息请点击：<a target="_blank" href="//m.capotfarm.com/guideline/list.do?q=%E5%A4%9A%E5%8F%91%E6%80%A7%E7%A1%AC%E5%8C%96">有关多发性硬化更多指南</a></ul>, tagList=[TagDto(tagId=3389, tagName=多发性硬化), TagDto(tagId=75333, tagName=认知评估)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5449, appHits=105, showAppHits=0, pcHits=3854, showPcHits=1917, likes=121, shares=2, comments=15, approvalStatus=1, publishedTime=Wed May 23 23:05:07 CST 2018, publishedTimeString=2018-05-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed May 23 23:05:07 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:02:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 意大利共识：多发性硬化患者认知评估)])
2018 意大利共识：多发性硬化患者认知评估
下载请点击：
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=881150, encodeId=05b488115049, content=阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:03:54 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319082, encodeId=a73f319082e1, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 27 14:44:37 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318789, encodeId=658c318e89e4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 26 20:32:24 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318129, encodeId=9e3a318129ea, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:52 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318128, encodeId=4a9a3181281d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:38 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2020-08-31 1488d5e7m58暂无昵称

    阅读

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=881150, encodeId=05b488115049, content=阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:03:54 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319082, encodeId=a73f319082e1, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 27 14:44:37 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318789, encodeId=658c318e89e4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 26 20:32:24 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318129, encodeId=9e3a318129ea, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:52 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318128, encodeId=4a9a3181281d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:38 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-27 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=881150, encodeId=05b488115049, content=阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:03:54 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319082, encodeId=a73f319082e1, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 27 14:44:37 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318789, encodeId=658c318e89e4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 26 20:32:24 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318129, encodeId=9e3a318129ea, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:52 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318128, encodeId=4a9a3181281d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:38 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-26 131****1460

    学习了受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=881150, encodeId=05b488115049, content=阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:03:54 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319082, encodeId=a73f319082e1, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 27 14:44:37 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318789, encodeId=658c318e89e4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 26 20:32:24 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318129, encodeId=9e3a318129ea, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:52 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318128, encodeId=4a9a3181281d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:38 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-24 Y—xianghai

    学习了长知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=881150, encodeId=05b488115049, content=阅读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 06:03:54 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319082, encodeId=a73f319082e1, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 27 14:44:37 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318789, encodeId=658c318e89e4, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 26 20:32:24 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318129, encodeId=9e3a318129ea, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:52 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=318128, encodeId=4a9a3181281d, content=学习了长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu May 24 09:43:38 CST 2018, time=2018-05-24, status=1, ipAttribution=)]
    2018-05-24 Y—xianghai

    学习了长知识

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2018 AAN实践指南建议：成人多发性硬化患者的疾病修饰治疗

美国神经病学学会(AAN,American Academy of Neurology) · 2018-04-23

2018 实践建议：接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理

国外神经内科相关专家小组（统称） · 2018-03-10

2018 ECTRIMS/EAN指南：多发性硬化患者的药物治疗

欧洲神经病学研究院(EAN,European Academy of Neurology) · 2018-01-11

多发性硬化影像诊断标准：中国专家共识

中国影像科相关专家小组 · 2017-02-20

多发性硬化诊断和治疗中国专家共识(2014版)

中华医学会神经病学分会神经免疫学组 · 2016-04-21

2014 NICE临床指南：在初级和二级医疗中多发性硬化的管理（CG186）

暂未更新 · 2014-10-15

Baidu
map
Baidu
map
Baidu
map